FABDURY
Live / Applied — First extension granted (statement of use) (as of 12 Mar 2026)
What this means for you
Not registered yet, but its 18 Oct 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98809303
- Mark type
- Stylized text
- Filed
- 18 Oct 2024
- Published for opposition
- 29 Apr 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating muscle diseases or disorders; pharmaceutical preparations for treating cardiac diseases or disorders; pharmaceutical preparations for treating metabolic diseases or disorders; pharmaceutical preparations for treating central nervous system diseases or disorders
Owner
- Dyne Therapeutics, Inc., Waltham, MA, US
- Dyne Therapeutics, Inc., Waltham, MA, US
Prosecution history
- 13 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2026 — SOU EXTENSION 1 GRANTED
- 12 Mar 2026 — SOU EXTENSION 1 FILED
- 12 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 14 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Sept 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 28 May 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 29 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Apr 2025 — PUBLISHED FOR OPPOSITION
- 23 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Mar 2025 — ASSIGNED TO EXAMINER
- 18 Oct 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Oct 2024 — NEW APPLICATION ENTERED